CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Anda juga dapat menghubungi kami: hubungi +44 2030978888 support@capital.com

Perdagangan Achieve Life Sciences, Inc. - ACHV CFD

4.91
1.64%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.27
Biaya inap posisi Long

Long position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.024068%
Biaya inap posisi short

Short position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
0.001846%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 4.87
Open* 4.88
1-Year Change* -1.21%
Day's Range* 4.79 - 4.95
52 wk Range 2.00-8.13
Average Volume (10 days) 97.08K
Average Volume (3 months) 2.10M
Market Cap 88.22M
P/E Ratio -100.00K
Shares Outstanding 17.93M
Revenue N/A
EPS -4.06
Dividend (Yield %) N/A
Beta 1.45
Next Earnings Date May 10, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jun 29, 2022 4.91 0.03 0.61% 4.88 4.95 4.79
Jun 28, 2022 4.87 -0.23 -4.51% 5.10 5.20 4.85
Jun 27, 2022 5.10 0.02 0.39% 5.08 5.14 4.91
Jun 24, 2022 5.15 0.05 0.98% 5.10 5.24 5.00
Jun 23, 2022 5.06 -0.08 -1.56% 5.14 5.32 5.06
Jun 22, 2022 5.12 0.03 0.59% 5.09 5.37 5.09
Jun 21, 2022 5.29 -0.24 -4.34% 5.53 5.63 5.28
Jun 17, 2022 5.49 0.01 0.18% 5.48 5.69 5.34
Jun 16, 2022 5.48 -0.35 -6.00% 5.83 5.83 5.45
Jun 15, 2022 5.90 -0.05 -0.84% 5.95 6.07 5.82
Jun 14, 2022 5.94 -0.13 -2.14% 6.07 6.12 5.87
Jun 13, 2022 5.99 -0.22 -3.54% 6.21 6.25 5.92
Jun 10, 2022 6.39 -0.16 -2.44% 6.55 6.55 6.39
Jun 9, 2022 6.57 0.06 0.92% 6.51 6.63 6.51
Jun 8, 2022 6.58 0.19 2.97% 6.39 6.60 6.39
Jun 7, 2022 6.55 0.09 1.39% 6.46 6.62 6.39
Jun 6, 2022 6.47 -0.14 -2.12% 6.61 6.71 6.46
Jun 3, 2022 6.63 -0.03 -0.45% 6.66 6.74 6.56
Jun 2, 2022 6.60 0.04 0.61% 6.56 6.63 6.56
Jun 1, 2022 6.54 -0.23 -3.40% 6.77 6.80 6.42

Achieve Life Sciences, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 0 0 0 0 0
Revenue
Total Operating Expense 40.8 33.094 14.75 16.528 12.813
Selling/General/Admin. Expenses, Total 10.722 9.128 7.868 6.854 6.945
Research & Development 30.078 23.966 6.882 9.674 5.868
Unusual Expense (Income) 0 0
Operating Income -40.8 -33.094 -14.75 -16.528 -12.813
Interest Income (Expense), Net Non-Operating -1.59 0.017 0.069 0.17 0.171
Other, Net 0.04 -0.075 -0.049 -0.037 -0.045
Net Income Before Taxes -42.35 -33.152 -14.73 -16.395 -12.687
Net Income After Taxes -42.35 -33.152 -14.73 -16.395 -12.687
Net Income Before Extra. Items -42.35 -33.152 -14.73 -16.395 -12.687
Net Income -42.35 -33.152 -14.73 -16.395 -12.687
Income Available to Common Excl. Extra. Items -42.35 -33.152 -14.73 -16.395 -12.687
Income Available to Common Incl. Extra. Items -42.35 -33.152 -14.73 -16.395 -12.687
Diluted Net Income -42.35 -33.152 -14.73 -16.395 -12.687
Diluted Weighted Average Shares 10.593 8.11984 2.71891 0.41232 0.17551
Diluted EPS Excluding Extraordinary Items -3.99791 -4.08284 -5.41761 -39.7628 -72.2861
Diluted Normalized EPS -3.99791 -4.08284 -5.41761 -39.7628 -72.2861
Gain (Loss) on Sale of Assets 0 0
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Total revenue 0 0 0 0 0
Total Operating Expense 10.862 12.639 10.073 7.226 7.115
Selling/General/Admin. Expenses, Total 2.248 2.77 2.866 2.838 2.609
Research & Development 8.614 9.869 7.207 4.388 4.506
Operating Income -10.862 -12.639 -10.073 -7.226 -7.115
Interest Income (Expense), Net Non-Operating -0.429 -0.408 -0.4 -0.353 0.003
Other, Net 0.059 -0.03 0.005 0.006 -0.039
Net Income Before Taxes -11.232 -13.077 -10.468 -7.573 -7.151
Net Income After Taxes -11.232 -13.077 -10.468 -7.573 -7.151
Net Income Before Extra. Items -11.232 -13.077 -10.468 -7.573 -7.151
Net Income -11.232 -13.077 -10.468 -7.573 -7.151
Income Available to Common Excl. Extra. Items -11.232 -13.077 -10.468 -7.573 -7.151
Income Available to Common Incl. Extra. Items -11.232 -13.077 -10.468 -7.573 -7.151
Diluted Net Income -11.232 -13.077 -10.468 -7.573 -7.151
Diluted Weighted Average Shares 13.5693 9.69379 9.64773 9.45875 9.4682
Diluted EPS Excluding Extraordinary Items -0.82775 -1.34901 -1.08502 -0.80063 -0.75527
Dividends per Share - Common Stock Primary Issue 0 0 0
Diluted Normalized EPS -0.82775 -1.34901 -1.08502 -0.80063 -0.75527
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 44.594 36.975 17.334 15.537 5.908
Cash and Short Term Investments 43.022 35.853 16.664 14.604 5.284
Cash
Cash & Equivalents 43.022 35.853 16.664 9.515 5.284
Short Term Investments 5.089
Total Receivables, Net 0.153 0.008 0.007 0.009
Accounts Receivable - Trade, Net 0.008 0.007 0.009
Prepaid Expenses 1.419 1.122 0.662 0.926 0.393
Total Assets 47.516 40.298 21.078 19.084 9.892
Property/Plant/Equipment, Total - Net 0.079 0.188 0.386 0.035 0.059
Property/Plant/Equipment, Total - Gross 0.366 0.82 0.986 0.755 1.144
Accumulated Depreciation, Total -0.287 -0.632 -0.6 -0.72 -1.085
Other Long Term Assets, Total 0.168 0.237 0.237 0.168 0.359
Total Current Liabilities 4.55 2.935 2.869 3.27 2.013
Accounts Payable 0.841 0.332 0.859 0.144 0.213
Accrued Expenses 3.709 2.603 2.01 3.126 1.773
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.027
Other Current Liabilities, Total 0
Total Liabilities 19.474 3.012 3.028 3.282 2.013
Total Long Term Debt 14.92 0 0 0 0
Long Term Debt 14.92
Total Equity 28.042 37.286 18.05 15.802 7.879
Common Stock 0.079 0.076 0.041 0.018 0.012
Additional Paid-In Capital 121.545 97.64 63.709 41.161 20.556
Retained Earnings (Accumulated Deficit) -93.586 -60.434 -45.704 -25.381 -12.694
Other Equity, Total 0.004 0.004 0.004 0.004 0.005
Total Liabilities & Shareholders’ Equity 47.516 40.298 21.078 19.084 9.892
Total Common Shares Outstanding 9.45354 6.11174 1.47426 0.33606 0.05978
Other Current Assets, Total 0 0.222
Goodwill, Net 1.034 1.034 1.034 1.034 1.034
Intangibles, Net 1.641 1.864 2.087 2.31 2.532
Deferred Income Tax 0
Other Liabilities, Total 0.004 0.077 0.159 0.012
Total Preferred Shares Outstanding 0 0.00112 0.00058
Redeemable Preferred Stock 0 0
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 37.692 44.594 34.733 42.431 30.439
Cash and Short Term Investments 36.337 43.022 33.312 42.001 29.637
Cash & Equivalents 36.337 43.022 33.312 42.001 29.637
Prepaid Expenses 1.355 1.419 1.27 0.43 0.802
Total Assets 40.614 47.516 37.799 45.565 33.662
Property/Plant/Equipment, Total - Net 0.049 0.079 0.1 0.121 0.141
Goodwill, Net 1.034 1.034 1.034 1.034 1.034
Intangibles, Net 1.586 1.641 1.697 1.752 1.809
Other Long Term Assets, Total 0.253 0.168 0.235 0.227 0.239
Total Current Liabilities 4.01 4.55 3.076 4.67 3.515
Accounts Payable 0.418 0.841 0.815 0.575 0.585
Accrued Expenses 3.592 3.709 2.261 4.095 2.93
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 19.181 19.474 3.099 4.711 3.574
Total Long Term Debt 15.171 14.92 0 0 0
Other Liabilities, Total 0 0.004 0.023 0.041 0.059
Total Equity 21.433 28.042 34.7 40.854 30.088
Redeemable Preferred Stock 0
Common Stock 0.079 0.079 0.079 0.079 0.076
Additional Paid-In Capital 122.509 121.545 121.052 120.515 98.441
Retained Earnings (Accumulated Deficit) -101.159 -93.586 -86.435 -79.744 -68.433
Other Equity, Total 0.004 0.004 0.004 0.004 0.004
Total Liabilities & Shareholders’ Equity 40.614 47.516 37.799 45.565 33.662
Total Common Shares Outstanding 9.47358 9.45354 9.45354 9.45222 6.14992
Total Preferred Shares Outstanding 0 0
Total Receivables, Net 0 0.153 0.151
Long Term Debt 15.171 14.92
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -33.152 -14.73 -16.395 -12.687 -10.583
Cash From Operating Activities -29.44 -13.474 -15.216 -10.623 -9.107
Cash From Operating Activities 0.027 0.032 0.031 0.06 0.059
Non-Cash Items 2.228 1.286 1.198 0.854 7.336
Changes in Working Capital 1.234 -0.285 -0.273 0.928 -3.091
Cash From Investing Activities -0.017 5.036 -5.125 12.648
Capital Expenditures -0.017 -0.053 -0.046
Other Investing Cash Flow Items, Total 5.089 -5.079 12.648
Cash From Financing Activities 36.61 32.68 17.325 19.757 2.001
Financing Cash Flow Items 27.87 12.334 4.96 1.937
Issuance (Retirement) of Stock, Net 21.681 4.81 4.991 14.797 0.064
Foreign Exchange Effects -0.001 0.004 0 -0.001
Net Change in Cash 7.169 19.189 7.149 4.009 5.541
Amortization 0.223 0.223 0.223 0.222 0.223
Deferred Taxes -3.051
Issuance (Retirement) of Debt, Net 14.929 0
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -7.573 -33.152 -26.001 -19.31 -7.999
Cash From Operating Activities -6.779 -29.44 -24.222 -15.528 -6.452
Cash From Operating Activities 0.25 0.188 0.127 0.064
Non-Cash Items 1.12 2.228 1.734 1.204 0.565
Changes in Working Capital -0.386 1.234 -0.143 2.451 0.918
Cash From Investing Activities 0 0 0
Capital Expenditures 0 0 0
Cash From Financing Activities 0.095 36.61 21.682 21.674 0.236
Issuance (Retirement) of Stock, Net 0.024 21.681 21.682 21.674 0.236
Net Change in Cash -6.685 7.169 -2.541 6.148 -6.216
Financing Cash Flow Items 0.071 0 0
Foreign Exchange Effects -0.001 -0.001 -0.001 0.002
Issuance (Retirement) of Debt, Net 14.929
Amortization 0.06
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
B. Riley Asset Management, LLC Investment Advisor/Hedge Fund 19.4865 3494000 0 2023-03-21 MED
Contrarian Alpha Management, L.L.C. Corporation 7.6288 1367873 1367873 2022-11-18
Francis Capital Management, LLC Hedge Fund 2.4117 432432 -161818 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.8976 340238 -8075 2022-12-31 LOW
Shay Capital LLC Hedge Fund 1.8962 340000 0 2022-12-31 HIGH
Long Focus Capital Management LLC Hedge Fund 1.7469 313220 5000 2022-12-31 MED
Perkins Capital Management, Inc. Investment Advisor 1.2164 218100 0 2022-12-31
LPL Financial LLC Investment Advisor 0.8271 148300 48400 2022-12-31 LOW
Wells Fargo Advisors Research Firm 0.7022 125910 -12000 2022-12-31 LOW
Raymond James & Associates, Inc. Research Firm 0.4978 89249 71818 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.4761 85365 -189 2022-12-31 LOW
Fichthorn (John) Individual Investor 0.3067 55000 0 2023-03-21 LOW
Citadel Advisors LLC Hedge Fund 0.283 50746 15746 2022-12-31 HIGH
Group One Trading, L.P. Research Firm 0.2751 49322 6861 2022-12-31 HIGH
Renaissance Technologies LLC Hedge Fund 0.2186 39200 500 2022-12-31 HIGH
Bencich (John A.) Individual Investor 0.2059 36920 22000 2022-11-18 MED
Diametric Capital Investment Advisor/Hedge Fund 0.1933 34660 15153 2022-09-30 HIGH
QS Investors, LLC_NLE Investment Advisor/Hedge Fund 0.1899 34050 33500 2021-06-30 LOW
Millennium Management LLC Hedge Fund 0.1697 30422 30422 2022-12-31 HIGH
Clearline Capital LP Hedge Fund 0.1515 27156 -92938 2022-12-31 HIGH

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Laba/Loss
Industry: Biotechnology & Medical Research (NEC)

22722 29Th Dr. Se
Suite 100
SEATTLE
WASHINGTON 98021
US

Income Statement

  • Annual
  • Quarterly

People also watch

XRP/USD

0.48 Price
+1.150% 1D Chg, %
Biaya inap posisi Long -0.0753%
Biaya inap posisi short 0.0069%
Waktu biaya inap 21:00 (UTC)
Spread 0.00428

Gold

1,955.00 Price
-0.060% 1D Chg, %
Biaya inap posisi Long -0.0180%
Biaya inap posisi short 0.0097%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

US100

12,643.10 Price
-0.390% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 1.8

Oil - Crude

73.47 Price
+0.770% 1D Chg, %
Biaya inap posisi Long -0.0180%
Biaya inap posisi short -0.0039%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda